<DOC>
	<DOCNO>NCT01784770</DOCNO>
	<brief_summary>To collect retrospectively efficacy safety information azithromycin IV patient Legionnaires ' disease related appropriate use daily practice .</brief_summary>
	<brief_title>Special Investigation Of Azithromycin IV For Legionnaires ' Disease ( Regulatory Post Marketing Commitment Plan )</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Legionnaires ' Disease</mesh_term>
	<mesh_term>Legionellosis</mesh_term>
	<criteria>All patient prescribe Azithromycin ( Zithromac ) IV Legionnaires ' disease . Patients prescribed Zithromac Zithromac SR .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Legionnaires ' disease</keyword>
	<keyword>Legionella pneumophila</keyword>
	<keyword>Zithromax</keyword>
	<keyword>Zithromac</keyword>
	<keyword>Japanese</keyword>
	<keyword>Regulatory Post Marketing Commitment Plan</keyword>
</DOC>